{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:45:53Z","timestamp":1791276353810,"version":"4.1.0"},"reference-count":116,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":137,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.jhep.2012.10.005","type":"journal-article","created":{"date-parts":[[2012,10,11]],"date-time":"2012-10-11T00:11:06Z","timestamp":1349914266000},"page":"564-574","source":"Crossref","is-referenced-by-count":138,"title":["Innate immunity and HCV"],"prefix":"10.1016","volume":"58","author":[{"given":"Markus H.","family":"Heim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2012.10.005_b0005","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1478-3231.2008.01934.x","article-title":"The global burden of hepatitis C","volume":"29","author":"Lavanchy","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2012.10.005_b0010","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1473-3099(05)70216-4","article-title":"Global epidemiology of hepatitis C virus infection","volume":"5","author":"Shepard","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jhep.2012.10.005_b0015","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jhep.2008.07.005","article-title":"Acute hepatitis C: current status and remaining challenges","volume":"49","author":"Santantonio","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2012.10.005_b0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM200107053450107","article-title":"Hepatitis C virus infection","volume":"345","author":"Lauer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2012.10.005_b0025","doi-asserted-by":"crossref","first-page":"e1261","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","author":"El-Serag","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2012.10.005_b0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-1-59745-394-3_4","article-title":"Nomenclature and numbering of the hepatitis C virus","volume":"510","author":"Kuiken","year":"2009","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jhep.2012.10.005_b0035","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jhep.2010.10.014","article-title":"Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies","volume":"54","author":"Zeisel","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2012.10.005_b0040","first-page":"453","article-title":"Replication of hepatitis C virus","volume":"5","author":"Moradpour","year":"2007","journal-title":"Nat Rev"},{"key":"10.1016\/j.jhep.2012.10.005_b0045","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jhep.2011.02.023","article-title":"Management of hepatitis C virus infection","volume":"55","author":"EASL Clinical Practice Guidelines","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2012.10.005_b0580","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/hep.24641","article-title":"An update on treatment of genotype 1 chronic hepatitis c virus infection: 2011 practice guidelines by the American association for the study of liver diseases","volume":"54","author":"Ghany","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.10.005_b0055","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1126\/science.282.5386.103","article-title":"Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy","volume":"282","author":"Neumann","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.jhep.2012.10.005_b0060","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.immuni.2006.08.007","article-title":"Type I interferons in host defense","volume":"25","author":"Stetson","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2012.10.005_b0065","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ni1112","article-title":"Toll-like receptor control of the adaptive immune responses","volume":"5","author":"Iwasaki","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2012.10.005_b0070","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2012.10.005_b0075","doi-asserted-by":"crossref","first-page":"15315","DOI":"10.1074\/jbc.R700007200","article-title":"Function of RIG-I-like receptors in antiviral innate immunity","volume":"282","author":"Yoneyama","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2012.10.005_b0080","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ni1087","article-title":"The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses","volume":"5","author":"Yoneyama","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2012.10.005_b0085","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/35099560","article-title":"Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3","volume":"413","author":"Alexopoulou","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2012.10.005_b0585","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1126\/science.1093616","article-title":"Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA","volume":"303","author":"Diebold","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jhep.2012.10.005_b0095","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1126\/science.1093620","article-title":"Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8","volume":"303","author":"Heil","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jhep.2012.10.005_b0100","doi-asserted-by":"crossref","first-page":"9237","DOI":"10.1073\/pnas.161293498","article-title":"Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition","volume":"98","author":"Bauer","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2012.10.005_b0105","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature04641","article-title":"IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9","volume":"440","author":"Hoshino","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2012.10.005_b0110","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/nature04193","article-title":"Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus","volume":"437","author":"Meylan","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2012.10.005_b0115","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.molcel.2005.08.014","article-title":"VISA is an adapter protein required for virus-triggered IFN-beta signaling","volume":"19","author":"Xu","year":"2005","journal-title":"Mol Cell"},{"key":"10.1016\/j.jhep.2012.10.005_b0120","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.cell.2005.08.012","article-title":"Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3","volume":"122","author":"Seth","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2012.10.005_b0125","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ni1243","article-title":"IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction","volume":"6","author":"Kawai","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2012.10.005_b0130","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1053\/j.gastro.2006.09.052","article-title":"Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics","volume":"131","author":"Marcello","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2012.10.005_b0135","doi-asserted-by":"crossref","first-page":"15623","DOI":"10.1073\/pnas.95.26.15623","article-title":"Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays","volume":"95","author":"Der","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2012.10.005_b0140","doi-asserted-by":"crossref","first-page":"e776","DOI":"10.1053\/j.gastro.2012.05.044","article-title":"Interferon-gamma-stimulated genes, but not USP18, are expressed in livers of patients with acute hepatitis C","volume":"143","author":"Dill","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2012.10.005_b0145","doi-asserted-by":"crossref","first-page":"7034","DOI":"10.1073\/pnas.0707882105","article-title":"Interferon signaling and treatment outcome in chronic hepatitis C","volume":"105","author":"Sarasin-Filipowicz","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2012.10.005_b0150","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1126\/science.8009221","article-title":"Functional role of type I and type II interferons in antiviral defense","volume":"264","author":"Muller","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.jhep.2012.10.005_b0155","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0092-8674(00)81289-1","article-title":"Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease","volume":"84","author":"Durbin","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2012.10.005_b0160","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/ng1097","article-title":"Impaired response to interferon-alpha\/beta and lethal viral disease in human STAT1 deficiency","volume":"33","author":"Dupuis","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2012.10.005_b0165","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex","volume":"4","author":"Kotenko","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2012.10.005_b0170","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1189\/jlb.0204117","article-title":"The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain","volume":"76","author":"Donnelly","year":"2004","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jhep.2012.10.005_b0175","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1126\/science.277.5332.1630","article-title":"STATs and gene regulation","volume":"277","author":"Darnell","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jhep.2012.10.005_b0180","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1126\/science.7871432","article-title":"Contribution of STAT SH2 groups to specific interferon signaling by the Jak-STAT pathway","volume":"267","author":"Heim","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.jhep.2012.10.005_b0185","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1126\/science.8197455","article-title":"Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins","volume":"264","author":"Darnell","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.jhep.2012.10.005_b0190","doi-asserted-by":"crossref","first-page":"7749","DOI":"10.1128\/JVI.02438-06","article-title":"Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases","volume":"81","author":"Zhou","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2012.10.005_b0195","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1634\/stemcells.19-5-378","article-title":"SOCS proteins: negative regulators of cytokine signaling","volume":"19","author":"Krebs","year":"2001","journal-title":"Stem Cells"},{"key":"10.1016\/j.jhep.2012.10.005_b0200","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0092-8674(00)80047-1","article-title":"SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine","volume":"98","author":"Alexander","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2012.10.005_b0205","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/ni1287","article-title":"Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity","volume":"7","author":"Fenner","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2012.10.005_b0210","doi-asserted-by":"crossref","first-page":"16608","DOI":"10.1074\/jbc.M208435200","article-title":"High-throughput immunoblotting. Ubiquitin-like protein ISG15 modifies key regulators of signal transduction","volume":"278","author":"Malakhov","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2012.10.005_b0215","doi-asserted-by":"crossref","first-page":"9976","DOI":"10.1074\/jbc.M109078200","article-title":"UBP43 (USP18) specifically removes ISG15 from conjugated proteins","volume":"277","author":"Malakhov","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2012.10.005_b0220","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1128\/MCB.19.4.3029","article-title":"A novel ubiquitin-specific protease, UBP43, cloned from leukemia fusion protein AML1-ETO-expressing mice, functions in hematopoietic cell differentiation","volume":"19","author":"Liu","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jhep.2012.10.005_b0225","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cell.2010.09.033","article-title":"Emerging role of ISG15 in antiviral immunity","volume":"143","author":"Skaug","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2012.10.005_b0230","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1089\/jir.2010.0110","article-title":"Interferon-stimulated gene 15 and the protein ISGylation system","volume":"31","author":"Zhang","year":"2011","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.jhep.2012.10.005_b0235","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.biocel.2011.06.006","article-title":"The ISG15\/USP18 ubiquitin-like pathway (ISGylation system) in hepatitis C virus infection and resistance to interferon therapy","volume":"43","author":"Chen","year":"2011","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.jhep.2012.10.005_b0240","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1073\/pnas.0607038104","article-title":"IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses","volume":"104","author":"Lenschow","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2012.10.005_b0245","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1128\/JVI.00105-08","article-title":"Mice lacking the ISG15 E1 enzyme UbE1L demonstrate increased susceptibility to both mouse-adapted and non-mouse-adapted influenza B virus infection","volume":"83","author":"Lai","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2012.10.005_b0250","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1099\/vir.0.015388-0","article-title":"ISG15, a ubiquitin-like interferon-stimulated gene, promotes hepatitis C virus production in vitro: implications for chronic infection and response to treatment","volume":"91","author":"Chen","year":"2010","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jhep.2012.10.005_b0255","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1038\/sj.emboj.7601149","article-title":"UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity","volume":"25","author":"Malakhova","year":"2006","journal-title":"EMBO J"},{"key":"10.1016\/j.jhep.2012.10.005_b0260","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1101\/gad.1010202","article-title":"Dysregulation of protein modification by ISG15 results in brain cell injury","volume":"16","author":"Ritchie","year":"2002","journal-title":"Genes Dev"},{"key":"10.1016\/j.jhep.2012.10.005_b0265","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1101\/gad.1056303","article-title":"Protein ISGylation modulates the JAK-STAT signaling pathway","volume":"17","author":"Malakhova","year":"2003","journal-title":"Genes Dev"},{"key":"10.1016\/j.jhep.2012.10.005_b0270","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1038\/nm1133","article-title":"Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection","volume":"10","author":"Ritchie","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2012.10.005_b0275","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1128\/MCB.00224-09","article-title":"Alpha interferon induces long-lasting refractoriness of JAK-STAT signaling in the mouse liver through induction of USP18\/UBP43","volume":"29","author":"Sarasin-Filipowicz","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jhep.2012.10.005_b0280","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/hep.24189","article-title":"Interferon-beta and interferon-lambda signaling is not affected by interferon-induced refractoriness to interferon-alpha in vivo","volume":"53","author":"Makowska","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.10.005_b0285","doi-asserted-by":"crossref","first-page":"10626","DOI":"10.1073\/pnas.95.18.10626","article-title":"Inhibition of Stat1-mediated gene activation by PIAS1","volume":"95","author":"Liu","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2012.10.005_b0290","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/ni1104","article-title":"PIAS1 selectively inhibits interferon-inducible genes and is important in innate immunity","volume":"5","author":"Liu","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2012.10.005_b0295","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.194.10.1395","article-title":"Determinants of viral clearance and persistence during acute hepatitis C virus infection","volume":"194","author":"Thimme","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2012.10.005_b0300","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.1128\/JVI.75.15.7059-7066.2001","article-title":"DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection","volume":"75","author":"Bigger","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2012.10.005_b0305","doi-asserted-by":"crossref","first-page":"15669","DOI":"10.1073\/pnas.202608199","article-title":"Genomic analysis of the host response to hepatitis C virus infection","volume":"99","author":"Su","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2012.10.005_b0310","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/hep.20239","article-title":"Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees","volume":"39","author":"Major","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.10.005_b0315","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1053\/j.gastro.2005.01.049","article-title":"Mathematical modeling of primary hepatitis C infection: noncytolytic clearance and early blockage of virion production","volume":"128","author":"Dahari","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2012.10.005_b0320","doi-asserted-by":"crossref","first-page":"15661","DOI":"10.1073\/pnas.202608299","article-title":"Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease","volume":"99","author":"Thimme","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2012.10.005_b0325","doi-asserted-by":"crossref","first-page":"27278","DOI":"10.1074\/jbc.M111.256974","article-title":"Molecular mechanism of signal perception and integration by the innate immune sensor retinoic acid-inducible gene-I (RIG-I)","volume":"286","author":"Binder","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2012.10.005_b0330","doi-asserted-by":"crossref","first-page":"12067","DOI":"10.1073\/pnas.0900971106","article-title":"5\u2032-Triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I","volume":"106","author":"Schmidt","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2012.10.005_b0335","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.immuni.2009.05.008","article-title":"Recognition of 5\u2032 triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus","volume":"31","author":"Schlee","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2012.10.005_b0340","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature07106","article-title":"Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA","volume":"454","author":"Saito","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2012.10.005_b0345","doi-asserted-by":"crossref","first-page":"8499","DOI":"10.1073\/pnas.0602957103","article-title":"Inhibition of dsRNA-induced signaling in hepatitis C virus-infected cells by NS3 protease-dependent and -independent mechanisms","volume":"103","author":"Cheng","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2012.10.005_b0350","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/hep.21829","article-title":"Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy","volume":"46","author":"Binder","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.10.005_b0355","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/hep.24580","article-title":"Hepatitis C virus induces interferon-lambda and interferon-stimulated genes in primary liver cultures","volume":"54","author":"Marukian","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.10.005_b0360","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1053\/j.gastro.2011.12.055","article-title":"HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons","volume":"142","author":"Thomas","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2012.10.005_b0590","doi-asserted-by":"crossref","DOI":"10.1002\/hep.25897","article-title":"IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection","author":"Park","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.10.005_b0370","doi-asserted-by":"crossref","first-page":"7431","DOI":"10.1073\/pnas.1002301107","article-title":"Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection","volume":"107","author":"Takahashi","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2012.10.005_b0375","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.1082604","article-title":"Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease","volume":"300","author":"Foy","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jhep.2012.10.005_b0380","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1073\/pnas.0408824102","article-title":"Immune evasion by hepatitis C virus NS3\/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF","volume":"102","author":"Li","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2012.10.005_b0385","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/hep.23426","article-title":"Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon system","volume":"51","author":"Bellecave","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.10.005_b0390","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jhep.2010.08.020","article-title":"Interferon-lambda serum levels in hepatitis C","volume":"54","author":"Langhans","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2012.10.005_b0395","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1159\/000329807","article-title":"Success and failure of virus-specific T cell responses in hepatitis C virus infection","volume":"29","author":"Neumann-Haefelin","year":"2011","journal-title":"Dig Dis"},{"key":"10.1016\/j.jhep.2012.10.005_b0400","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1053\/j.gastro.2008.12.034","article-title":"Analysis of CD8+ T-cell-mediated inhibition of hepatitis C virus replication using a novel immunological model","volume":"136","author":"Jo","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2012.10.005_b0405","doi-asserted-by":"crossref","first-page":"13779","DOI":"10.1128\/JVI.78.24.13779-13792.2004","article-title":"Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees","volume":"78","author":"Bigger","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2012.10.005_b0410","doi-asserted-by":"crossref","first-page":"e1010","DOI":"10.1053\/j.gastro.2010.11.039","article-title":"Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C","volume":"140","author":"Dill","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2012.10.005_b0415","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1053\/j.gastro.2010.04.049","article-title":"Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C","volume":"139","author":"Honda","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2012.10.005_b0595","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1002\/hep.23912","article-title":"IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C","volume":"52","author":"Urban","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.10.005_b0425","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1053\/j.gastro.2005.01.059","article-title":"Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection","volume":"128","author":"Chen","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2012.10.005_b0430","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/gut.2007.128611","article-title":"Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C","volume":"57","author":"Asselah","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2012.10.005_b0435","doi-asserted-by":"crossref","first-page":"8469","DOI":"10.1128\/JVI.73.10.8469-8475.1999","article-title":"Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway","volume":"73","author":"Heim","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2012.10.005_b0440","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/S0016-5085(03)00290-7","article-title":"Expression of hepatitis c virus proteins inhibits interferon alpha signaling in the liver of transgenic mice","volume":"124","author":"Blindenbacher","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2012.10.005_b0445","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/j.gastro.2003.10.076","article-title":"Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A","volume":"126","author":"Duong","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2012.10.005_b0450","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.chom.2009.11.004","article-title":"Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation","volume":"6","author":"Garaigorta","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jhep.2012.10.005_b0455","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature09907","article-title":"A diverse range of gene products are effectors of the type I interferon antiviral response","volume":"472","author":"Schoggins","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2012.10.005_b0460","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/hep.21853","article-title":"Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response","volume":"46","author":"Feld","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.10.005_b0465","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2012.10.005_b0600","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1053\/j.gastro.2009.12.056","article-title":"Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study","volume":"138","author":"Rauch","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2012.10.005_b0475","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2012.10.005_b0480","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C","volume":"41","author":"Tanaka","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2012.10.005_b0485","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ng.447","article-title":"IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy","volume":"41","author":"Suppiah","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2012.10.005_b0605","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/nature04226","article-title":"A haplotype map of the human genome","volume":"437","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2012.10.005_b0495","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ng.447","article-title":"IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy","volume":"41","author":"Suppiah","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2012.10.005_b0500","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C","volume":"41","author":"Tanaka","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2012.10.005_b0610","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1053\/j.gastro.2010.07.005","article-title":"A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice","volume":"139","author":"Tillmann","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2012.10.005_b0615","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1053\/j.gastro.2010.07.058","article-title":"Variants in IL28B in liver recipients and donors correlate with response to peg-interferon and ribavirin therapy for recurrent hepatitis C","volume":"139","author":"Fukuhara","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2012.10.005_b0515","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/TP.0b013e31825668f6","article-title":"Increased risk of severe hepatitis C virus recurrence after liver transplantation in patients with a T allele of IL28B rs12979860","volume":"94","author":"Cisneros","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2012.10.005_b0520","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/TP.0b013e3182547551","article-title":"The course of posttransplant hepatitis C infection: comparative impact of donor and recipient source of the favorable IL28B genotype and other variables","volume":"94","author":"Duarte-Rojo","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2012.10.005_b0525","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/lt.22235","article-title":"Relationship between the interleukin-28b gene polymorphism and the histological severity of hepatitis C virus-induced graft inflammation and the response to antiviral therapy after liver transplantation","volume":"17","author":"Eurich","year":"2011","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2012.10.005_b0620","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/hep.24074","article-title":"IL28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection","volume":"53","author":"Charlton","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.10.005_b0535","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1600-6143.2011.03491.x","article-title":"Donor and recipient IL28B polymorphisms in HCV-infected patients undergoing antiviral therapy before and after liver transplantation","volume":"11","author":"Coto-Llerena","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2012.10.005_b0540","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jhep.2010.10.037","article-title":"Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection","volume":"55","author":"Lange","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2012.10.005_b0545","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/vir.0.83391-0","article-title":"Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures","volume":"89","author":"Randall","year":"2008","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jhep.2012.10.005_b0625","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1126\/science.1178178","article-title":"Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection","volume":"327","author":"Lanford","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.jhep.2012.10.005_b0555","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/hep.23690","article-title":"Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin","volume":"52","author":"Akuta","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.10.005_b0560","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa1013086","article-title":"Telaprevir for retreatment of HCV infection","volume":"364","author":"Zeuzem","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2012.10.005_b0565","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1056\/NEJMoa1012912","article-title":"Telaprevir for previously untreated chronic hepatitis C virus infection","volume":"364","author":"Jacobson","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2012.10.005_b0570","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa1009482","article-title":"Boceprevir for previously treated chronic HCV genotype 1 infection","volume":"364","author":"Bacon","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2012.10.005_b0575","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1010494","article-title":"Boceprevir for untreated chronic HCV genotype 1 infection","volume":"364","author":"Poordad","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2012.10.005_b0630","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.cyto.2012.06.015","article-title":"Interferon signaling in the liver during hepatitis C virus infection","volume":"59","author":"Makowska","year":"2012","journal-title":"Cytokine"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827812007726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827812007726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T13:37:21Z","timestamp":1594733841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827812007726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":116,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0168827812007726"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2012.10.005","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}